Apollo Hospitals Enterprise Limited has posted net profit of Rs. 317.11 crores for the period ended June 30, 2022 as against net profit of Rs. 90.14 crores for the period ended March 31, 2022. The company posted net profit of Rs.489.28 crores for the period ended June 30, 2021.

The company has reported total income of Rs. 3811.66 crores during the period ended June 30, 2022 as compared to Rs. 3577.15 crores during the period ended March 31, 2022. It reported total income of Rs.3784.85 crores during the period ended June 30, 2021.

Dr Prathap C. Reddy, Chairman, Apollo Hospital Group said, “The first quarter of the new financial year has seen a definitive increase in the demand for non-COVID health services and augurs well for growth this financial year. We have been able to serve a larger number of patients with non-communicable diseases (NCDs) and restore them to health. At the same time, our focus on preventive healthcare has continued to help patients manage chronic conditions and nip them in the bud.

With the overall economy emerging from the shadow of the pandemic, we have seen people returning to office and life coming back to normal. However, we continue to maintain precautions against COVID and remain vigilant and prepared against new infections such as monkeypox, which has been declared as a global health emergency by the World Health Organisation.

We are glad to report increased progress in our digital initiatives. Our cardiovascular risk assessment tool is now integrated with Singapore-based ConnectedLife’s digital wellness solutions and is an acknowledgement of our innovative work in preventive healthcare.

We are the first system in Asia Pacific to be awarded three Stage 6 certifications for HIMSS (Healthcare Information and Management Systems Society) digital maturity models and  the second system in the world to be awarded a Stage 6 DIAM certification. The DIAM validation commended us for our use of biomarkers, molecular imaging, and mapping software. Our patient portal was commended as “one of the finest examples of patient communication" with multiple functionalities, including appointment setting, health monitoring and device integration capability.

It is recognition such as this that continues to motivate us to grow our digital health capabilities and leverage the full potential of digital technology for the best patient outcomes. Our aim remains to empower our patients and encourage them to proactively manage their own health, a factor that is increasingly considered as vital to improve the quality of healthcare. Our digital prowess is also empowering our doctors with digital tools to help patients realize their health goals.

We are also preparing to utilize the power of 5G in healthcare. 5G technology can provide a solid security foundation for sharing vital patient data remotely. We partnered with Airtel and CISCO on a use case of a 5G connected ambulance to showcase how 5G technology can virtually transport doctors into the Ambulance to provide critical care even as the patient is enroute to the hospital in an emergency.

We are excited about our acquisition of the hospital asset in Gurgaon, and we look forward to taking our unique brand of world class clinical outcomes to the fast-growing and discerning city.

All our centres of excellence are now performing effectively and efficiently with digitization integrated into the healthcare delivery ecosystem.

Out digital healthcare services platform Apollo 24/7 is also progressing faster than planned, with our physical pharmacy network poised to touch 5000 stores. Apollo Hospitals is now well poised to grow across all verticals this year !”

During the quarter, Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore. The asset has a potential for 650 beds over 700,000 square feet and will be commissioned in 24 months. The acquisition marks the entry of Apollo in the state of Haryana with the promise of a world-class hospital to serve both local and international patients.

It also tied up with Imperial hospitals Bangladesh to manage their 375-bed hospital in Chittagong, Bangladesh. Apollo has a very strong brand equity in Bangladesh and we hope to leverage this to further enhance our clinical value proposition for Bangladesh.

The company achieved stage 6 accreditations from Healthcare Information and Management Systems Society (HIMSS), including being only the second healthcare provider worldwide for Digital Imaging Adoption Model (DIAM) Apollo integrated its proprietary AI based Cardiovascular diseases tool (AIVCD) with Singapore based ConnectedLife’s digital wellness solutions to dramatically improve accuracy of cardiac disease prediction.

Apollo Education UK (AEUK) introduced the International Clinical Fellowship Programme (ICFP) for Doctors in collaboration with Global Training and Education Centre (GTEC) at Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, and Edge Hill University, UK.